Aurinia Pharmaceuticals Aktie
12,16
EUR
-0,22
EUR
-1,78
%
14,42
USD
-0,18
USD
-1,23
%
Werbung
Aurinia Pharmaceuticals Aktie Analyse
| 16.03.18 | Aurinia Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 08.02.18 | Aurinia Pharmaceuticals Outperform | RBC Capital Markets | |
| 30.10.17 | Aurinia Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 18.05.17 | Aurinia Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 11.04.17 | Aurinia Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 22.03.17 | Aurinia Pharmaceuticals Outperform | FBR & Co. | |
| 30.12.16 | Aurinia Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 30.06.16 | Aurinia Pharmaceuticals Buy | H.C. Wainwright & Co. | |
|
Werbung
|
|||
| 08.05.15 | Aurinia Pharmaceuticals Buy | MLV Capital | |
Werbung
Werbung